In a retrospective study, 365 patients who developed liver disease above 18 years of age, who underwent sequencing of cholestasis genes for therapeutic purposes were identified; 28.4% of patients had potentially disease-causing variants of ABCB4, ABCB11, and ATP8B1genes with different liver disease phenotypes. This evidence concerns the gene ABCB4 and cholestasis.